Internal Medicine, Medical Oncology · Philadelphia, PA
NPI
1922340090
Since 2013
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
333 Cottman Ave
Philadelphia, PA, 19111
Phone (215) 728-2500
Groups this clinician bills Medicare through
Medicare paid, 2024
$78K
749 services
Medicare patients, 2024
231
Average age 74
Drug cost, 2024
$5.5M
1,561 prescriptions
Company payments, 2025
$152
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Fern M Anari was code 99215 (office e&m - established), 223 times for 94 patients. In total Fern M Anari billed 749 services in 10 codes, and Medicare paid $78K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-06-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 223 | 94 | $103.87 | $23K |
| 99214 Office E&M - Established | Facility | 177 | 108 | $69.67 | $12K |
| 99215 Office E&M - Established | Office | 119 | 62 | $147.04 | $17K |
| 99214 Office E&M - Established | Office | 118 | 75 | $104.30 | $12K |
| 99204 Office E&M - New | Facility | 35 | 35 | $103.50 | $3,622 |
| 99205 Office E&M - New | Facility | 33 | 33 | $146.07 | $4,820 |
By year: 2022 $52K for 530 services; 2023 $44K for 430 services; 2024 $78K for 749 services.
Medicare prescription drug claims, 2024
In 2024, the drug Fern M Anari prescribed most often to Medicare patients was Abiraterone Acetate, with 397 prescriptions and refills. In total Fern M Anari wrote 1,561 Medicare prescriptions that cost $5.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Abiraterone Acetate Generic | 397 | 401 | 53 | $651K |
| Prednisone Generic | 388 | 412 | 61 | $1,155 |
| Orgovyx Relugolix | 105 | 105 | 20 | $274K |
| Inlyta Axitinib | 98 | 98 | 15 | $1.9M |
| Amlodipine Besylate Generic | 65 | 87 | 13 | $406 |
| Nubeqa Darolutamide | 56 | 56 | Under 11 | $730K |
| Xtandi Enzalutamide | 51 | 53 | 11 | $669K |
| Ondansetron Hcl Generic | 48 | 50 | 34 | $311 |
| Cabometyx Cabozantinib S-Malate | 27 | 27 | Under 11 | $534K |
| Dexamethasone Generic | 25 | 25 | 20 | $365 |
| Prochlorperazine Maleate Generic | 23 | 23 | 18 | $183 |
| Bicalutamide Generic | 23 | 25 | 22 | $329 |
| Oxycodone Hcl Generic | 19 | 19 | Under 11 | $298 |
| Eliquis Apixaban | 19 | 20 | Under 11 | $11K |
| Levothyroxine Sodium Generic | 17 | 25 | Under 11 | $105 |
Brand drugs: 407 claims; generic drugs: 1,154 claims; opioid claims: 39.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Fern M Anari $152 ($152 in general payments such as food, travel and fees) from 6 companies. The largest payer was Pfizer Inc. with $115.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.